AUTL analyst estimates
Autolus Therapeutics (AUTL) analyst ratings, the average price target and its range, and every firm's latest call.
- 3 firms rate AUTL: 3 buy, 0 hold, 0 sell.
- The average price target is $8.87 from None analysts, from $7.60 to $11.00.
AUTL analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Nov 18, 2024 | Goldman Sachs | Goldman Sachs Upgrades Autolus Therapeutics plc (AUTL) to Buy | $7.60 |
| May 20, 2024 | Wells Fargo | Wells Fargo Reiterates Overweight Rating on Autolus Therapeutics plc (AUTL) | $8.00 |
| Apr 8, 2024 | Truist Financial | Autolus Therapeutics plc (AUTL) PT Raised to $11 at Truist Securities | $11.00 |
| Mar 15, 2024 | Truist Financial | Autolus Therapeutics plc (AUTL) PT Raised to $10 at Truist Securities | $10.00 |